Keywords: update, antisoma, as1404, substantial, survival, benefit, over

UPDATE: Antisoma's AS1404: substantial survival benefit over chemo

Article | 23 October 2006

Print This

UK cancer drug developer Antisoma has reported strong final data from a Phase II trial of AS1404 in non-small cell ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in